Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Neuromodulation. 2022 Nov 23;26(4):715–727. doi: 10.1016/j.neurom.2022.10.044

Table 1.

Considered factors related to the study methodology, population and intervention used to create the variables used in the analysis.

Study Methodology Population Intervention
- Use of intention-to-treat analysis - Age - Use of tDCS with a combined intervention
- Size of intervention groups - Duration of symptoms - Type of combined intervention
- Dropouts in intervention groups - Gender - Timing of combined intervention
- Disease diagnostic definition criteria - Race - Total number of intervention sessions
- Blinding of study subject - Body mass index - Frequency of intervention sessions per week
- Blinding of intervention staff - Number of subjects with another chronic illness - Duration of tDCS intervention in weeks
- Baseline depression level - Patient setting
- Baseline anxiety level - Type of tDCS montage
- Baseline pain catastrophizing score - Number of stimulation channels
- Percentage of subjects using opioids - Stimulation polarity
- Percentage of subjects using gabapentinoids - Active electrode location
- Percentage of subjects using antidepressants - tDCS current intensity parameter (mA)
- Percentage of subjects using anticonvulsants - tDCS session duration
- Percentage of subjects using analgesics - tDCS electrode surface area
- Percentage of subjects using myorelaxants
- Disability score at baseline
- Sleep quality score at baseline
- Baseline pain Level (Active and Sham groups)